Centre of Excellence for 3D bioprinting inaugurated at IISc Bangalore

Earlier in August this year, IISc Bangalore and CELLINK had announced their partnership to set up the CoE after a memorandum of understanding (MoU) was signed to formalise the collaboration on August 18.

The centre will provide access to 3D bioprinting systems, and focus on advancing research on heart, bone, cartilage and cancer through the use of 3D bioprinting.

IISc director Professor Govindan Rangarajan said, “IISc and CELLINK will work together to conduct workshops aimed at providing the necessary skills to utilise 3D bioprinting and to reap the benefits of 3D cell culture. The two will undertake and advise on research projects related to tissue engineering, drug discovery, material science and regenerative/ personalised medicine.”

3D bioprinting is the method of printing three dimensional biomedical structures. Currently, it can be used to print tissue and organ models to help research drugs and potential treatments. The technology will also have an impact on human health by promoting drug discovery, testing and regenerating tissues for therapies.